EWTX
Edgewise Therapeutics Inc
NASDAQ: EWTX · HEALTHCARE · BIOTECHNOLOGY
$30.45
-1.74% today
Updated 2026-04-29
Market cap
$3.27B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.63
Dividend yield
—
52W range
$12 – $35
Volume
0.9M
Edgewise Therapeutics Inc (EWTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $24.54M | $131.14M | $285.23M | $367.10M | $340.04M | $486.82M |
| Cash & equivalents | $23.65M | $104.92M | $15.57M | $21.99M | $86.10M | $41.67M |
| Current assets | $24.04M | $129.65M | $283.77M | $357.00M | $327.00M | $475.48M |
| Total liabilities | $41.39M | $164.56M | $10.85M | $20.39M | $21.20M | $27.60M |
| Current liabilities | $1.13M | $4.34M | $10.52M | $16.59M | $16.77M | $23.86M |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $-16.85M | $-33.42M | $274.38M | $346.72M | $318.83M | $459.22M |
| Retained earnings | $-17.02M | $-34.15M | $-76.96M | $-144.60M | $-244.76M | $-378.58M |
| Accounts receivable | — | — | $548000.00 | $251000.00 | — | — |
| Inventory | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — |